Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of ...

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...

This marks Marius Pharmaceuticals' fifth U.S. patent, further reinforcing its leadership in the field of testosterone replacement therapy. The newly allowed patent specifically covers the company's ...

U.S. Rep. Lois Frankel, D-West Palm Beach, criticized the Trump Administration's efforts to close the U.S. Department of ...

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; Supports Front-Line Treatment Potential Clinical Pipeli ...

R&D innovation is likely to remain a major focus area in 2025 . M&A activity is also expected to remain strong, particularly with Trump’s return to the White House.Regular pipeline setbacks, slow ramp ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in ...

From mice performing first aid to birds using antioxidants, animals display remarkable self-medication behaviors that could ...

According to an Arizona Board of Regents report, federal funds make up the biggest chunk of research funding for the state’s ...

Providing a therapy that meets the needs of a client is far more complex than prescribing the "right" antibiotic to treat an infection.

PACS Group (NYSE: PACS) leaders are facing a shareholder lawsuit tied to an alleged scheme to submit false Medicare claims. Five PACS executives, ...